LightNews
rachelhclare.bsky.social
@rachelhclare.bsky.social
10 followers 10 following 5 posts
Posts Media Videos Starter Packs
Pinned
rachelhclare.bsky.social
rachelhclare.bsky.social @rachelhclare.bsky.social · Feb 11
Last week I had the great pleasure in hosting the launch meeting of our NC3Rs project grant now known as G.E.M (Galleria Envenoming Model). Our work is focused on developing and validating an alternative model to assess venom lethality and therapeutic efficacy testing.
2 3 4
rachelhclare.bsky.social
rachelhclare.bsky.social @rachelhclare.bsky.social · Feb 11
We are incredibly grateful to have Emeritus Prof. José María Gutiérrez from ICP and Prof. Nicholas Casewell from CSRI forming our advisory panel. Their expertise and invaluable insights will be instrumental in guiding our vision.
rachelhclare.bsky.social
rachelhclare.bsky.social @rachelhclare.bsky.social · Feb 11
The team are incredibly grateful to be supported by our partners Stuart Ainsworth from Liverpool University and the antivenom manufacturer Instituto Clodomiro Picado (ICP) of the Universidad de Costa Rica.
rachelhclare.bsky.social
rachelhclare.bsky.social @rachelhclare.bsky.social · Feb 11
We look forward to sharing our progress from the team including the Principle investigators @rachelhclare.bsky.social from Edge Hill University, @menzieslab.bsky.social @blslancasteruni.bsky.social, and Prof. James Wakefield @lsiexeter.bsky.social @gmrcuk.bsky.social & @jamescpearce.bsky.social.
1 1
rachelhclare.bsky.social
rachelhclare.bsky.social @rachelhclare.bsky.social · Feb 11
nc3rs.org.uk/our-portfoli...
Development of Galleria mellonella as a replacement preclinical model for snakebite envenoming to reduce the need for murine models
nc3rs.org.uk
1
rachelhclare.bsky.social
rachelhclare.bsky.social @rachelhclare.bsky.social · Feb 11
Last week I had the great pleasure in hosting the launch meeting of our NC3Rs project grant now known as G.E.M (Galleria Envenoming Model). Our work is focused on developing and validating an alternative model to assess venom lethality and therapeutic efficacy testing.
2 3 4